First Tracks Biotherapeutics, Inc. TRAX
—
34.42
(1.41)
(3.94%)
as of 25 Sep
- Market cap
- $1.3B
- P/E
- —
Follow TRAX
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
14.28 | 8.74 | 10.20 | — |
+1 more quarter Free account |
Net Debt/EBITDA |
4.86 | 5.44 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | — | — | — | |
Operating CF/Net income |
0.96 | 0.65 | — | 0.91 | |
Capex/Depreciation |
(0.07) | (0.15) | — | 0.04 | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Free Cash Flow per Share |
(0.91) | 0.00 | — | (1.34) | |
Cash per Share |
4.80 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
4.82 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | — | — | 0.00 | |
Book value per Share |
4.82 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(31.94) | (32.58) | — | (38.68) | |
Working Capital |
165.30 | 256.29 | 285.38 | — | |
Capital Expenditures |
(0.02) | (0.02) | — | (0.04) | |
Net Current Asset Value |
163.40 | 256.29 | 273.35 | 0.00 | |
| Other line items | |||||
Quick Ratio |
13.50 | 8.65 | 10.05 | — | |
Revenue per Share |
0.00 | — | — | 0.00 | |
Operating CF per Share |
(0.91) | 0.00 | — | (1.34) | |
Capex per Share |
0.00 | 0.00 | — | 0.00 | |
Average Assets |
91.57 | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | — | 0.00% |
Columns are period end dates